CD44 and central nervous system cancer: Glioma cells are now believed to originate from a neural stem cell of different commitment state (Alcantara Llaguno and Parada, 2016), therefore “glioma stem cells” and NSCs share common phenotypic markers (CD133, CD44, CD15), as well as activated molecular pathways.